| Symbol | VOR |
|---|---|
| Name | VOR BIOPHARMA INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 100 CAMBRIDGEPARK DRIVE,SUITE 101, CAMBRIDGE, Massachusetts, 02140, United States |
| Telephone | +1 617 655-6580 |
| Fax | — |
| — | |
| Website | https://www.vorbio.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001817229 |
| Description | Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The companys products include VOR33. Additional info from NASDAQ: |
New Form SCHEDULE 13G/A - Vor Biopharma Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001231919-26-000936 <b>Size:</b> 18 KB
Read moreVor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Read moreNew Form SCHEDULE 13G/A - Vor Biopharma Inc. <b>Filed:</b> 2026-08-07 <b>AccNo:</b> 0000315066-26-002253 <b>Size:</b> 11 KB
Read moreRA CAPITAL MANAGEMENT, L.P. 🟡 adjusted position in 213 shares (1 derivative) of Vor Biopharma Inc. (VOR) at $19.75 Transaction Date: Jul 16, 2026 | Filing ID: 000776
Read moreNew Form SCHEDULE 13D/A - Vor Biopharma Inc. <b>Filed:</b> 2026-07-21 <b>AccNo:</b> 0001346824-26-000197 <b>Size:</b> 17 KB
Read moreRA CAPITAL MANAGEMENT, L.P. 🟢 acquired 57.2K shares (1 derivative) of Vor Biopharma Inc. (VOR) at $14.09 Transaction Date: Jun 11, 2026 | Filing ID: 000633
Read more